Ordering Codeine in Connecticut

About Codeine (codeine phosphate)

Codeine is the brand name for codeine phosphate, a medication belonging to the opioid analgesic drug class. Codeine is classified as a Schedule III (C-III) (Schedule II when combined with certain drugs) under the federal Controlled Substances Act, indicating its medical applications alongside recognized potential for dependence.

Codeine works by is metabolized to morphine in the liver, which then binds to mu-opioid receptors to provide analgesia and antitussive effects. This mechanism of action gives Codeine its therapeutic effects for the treatment of mild to moderate pain and cough suppression. Brand-name Codeine and generic codeine phosphate are both available, providing options for patients and prescribers.

As a controlled substance, Codeine requires a current prescription from a certified clinician in all U.S. states. It cannot be purchased over the counter. The prescribing, dispensing, and monitoring of Codeine are regulated at both the federal and state levels to ensure safe and appropriate use.

Codeine in Connecticut

In Connecticut, all regulated substances require a current prescription from a licensed Connecticut healthcare provider. The Connecticut Board of Pharmacy regulates pharmacies operating in the state, and all pharmacies—including web-based pharmacies—must be licensed by the board. Connecticut has a Prescription Drug Monitoring Program called the Connecticut Prescription Monitoring Program (PMP), and prescribers are required to check this system before prescribing Schedule II medications. The state's telehealth framework allows controlled substance prescribing via virtual visits, though an initial real-time audio-visual consultation is typically required.

All prescriptions for Codeine in Connecticut must be issued by a provider who has conducted a thorough evaluation of the patient's medical condition, needs, and risk factors. The prescribing provider must be licensed to practice in Connecticut and must comply with all applicable state and federal regulations.

How Telehealth Works in Connecticut

Connecticut permits telehealth prescribing of regulated substances following an initial evaluation. The state has telehealth parity legislation and requires providers to be licensed in Connecticut. Audio-visual communication is required for initial encounters.

For Codeine specifically, Connecticut providers can prescribe this medication via telehealth once a legitimate provider-patient relationship has been established. The Connecticut Medical Board and Board of Pharmacy both provide guidance on telehealth prescribing standards.

Telehealth can increase access to healthcare for patients in rural areas, those with mobility limitations, or individuals who have difficulty scheduling in-person appointments. However, telehealth is not appropriate for all situations. Your provider will determine whether telehealth is suitable for your specific case.

Prescription Drug Monitoring in Connecticut

Connecticut operates the Connecticut Prescription Monitoring Program (PMP) as its Prescription Drug Monitoring Program. This system tracks all controlled substance prescriptions dispensed within the state, helping prescribers and pharmacists identify potential issues such as duplicate prescriptions, dangerous drug combinations, or signs of misuse.

Before prescribing Codeine or any controlled substance, Connecticut providers are required to check the Connecticut Prescription Monitoring Program (PMP). This is a critical safety measure that helps protect patients while ensuring access to necessary medications.

Important Safety Information

The following safety information is specific to Codeine (codeine phosphate) and its drug class. This is not a complete list of warnings and precautions. Always consult your healthcare provider for comprehensive safety guidance.

• Respiratory depression: Codeine can cause life-threatening respiratory depression, especially in opioid-naive patients, the elderly, or those with respiratory conditions. Risk increases with higher doses and concurrent CNS depressant use.
• Dependence and addiction: Codeine carries a high risk of physical dependence, psychological addiction, and abuse. Even at recommended doses, prolonged use can lead to dependence. Use only as prescribed.
• Overdose risk: Codeine overdose can be fatal. Signs include extreme drowsiness, pinpoint pupils, slow or stopped breathing, and loss of consciousness. Have naloxone available if prescribed opioids.
• Serotonin syndrome: When combined with serotonergic drugs, Codeine may cause serotonin syndrome, a potentially life-threatening condition. Symptoms include agitation, hallucinations, rapid heartbeat, and muscle rigidity.
• Neonatal opioid withdrawal syndrome: Prolonged use during pregnancy may result in neonatal withdrawal syndrome, which can be life-threatening if not recognized and treated.

Related Resources